Magnetic Nanoparticles for Ectopic Pregnancy

Researchers at Oregon State University have successfully developed an innovative nanomedicine approach using cobalt-doped soft ferromagnetic iron oxide nanoparticles to detect and treat dangerous ectopic pregnancies in mice. Approximately 98 percent of ectopic pregnancies occur in the fallopian tubes, representing about 2 percent of all pregnancies in the United States, roughly 100000 cases annually, and remaining a leading cause of first-trimester maternal mortality. The research team, led by Olena Taratula and Karthickraja Duraisamy, aims to address the significant limitations and high misdiagnosis or failure rates associated with traditional diagnostic tools like transvaginal ultrasound and treatments such as methotrexate. By intravenously administering engineered nanoparticles that selectively accumulate in the placenta, the technology enables precise visualization via magnetic resonance imaging without crossing the placental barrier into the embryo. When these nanoparticles concentrate in improperly located gestational sacs, such as inside a fallopian tube, exposure to an alternating magnetic field induces controlled local hyperthermia of up to 45 degrees Celsius. This magnetic heating mechanism successfully disrupts placental function and destroys targeted gestational sacs while preserving surrounding uterine tissue and fertility in pregnant mice, avoiding invasive surgery. Published on September 17, 2026, in the journal Biomaterials, this breakthrough remains at the animal-testing stage, requiring extensive validation in other animal models before human clinical translation. Financial support for the study was provided by Oregon State University College of Pharmacy, the National Institutes of Health, and Oregon Health and Science University.